Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018

Max W. Adelman, Dana Goodenough, Samantha Sefton, Carolyn Mackey, Stepy Thomas, Scott K. Fridkin, Michael H. Woodworth

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan Atlanta, Georgia in 2018, over half did not receive first-line treatment, although guideline adherence increased over the year. Second-line treatment was more common in patients treated in ambulatory settings.

Original languageEnglish (US)
Article number102364
JournalAnaerobe
Volume70
DOIs
StatePublished - Aug 2021

Keywords

  • Clostridioides difficile infection
  • Guideline-adherent treatment
  • Metronidazole
  • Vancomycin

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018'. Together they form a unique fingerprint.

Cite this